Posts

How To Quit Smoking With CBD

If you smoke, chances are you’ve thought about quitting or have even tried to at...

Teva Secures $100M Funding to Expedite Schizophrenia Dr...

Teva has tapped into royalty funding to speed up the development of an antipsych...

New York University Study Finds Prominent Breakthrough ...

Researchers at New York University have made an important discovery in the field...

Pfizer’s Cost-Cutting Measures Impact UK’s Sandwich Sit...

Earlier this month, Pfizer, the pharmaceutical giant, extended its cost-cutting ...

Novo Says Weight Loss Alone Isn’t to Thank For Wegovy’s...

Novo Nordisk unveiled fresh findings at a prominent medical conference, indicati...

Plocabulin by Pharma Mar for Biliary Tumor: Likelihood ...

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Adenocarcinoma: Likelihood...

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Peritoneal Cancer: Likelih...

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Plocabulin by Pharma Mar for Epithelial Ovarian Cancer:...

Plocabulin is under clinical development by Pharma Mar and currently in Phase I ...

Pembrolizumab by Merck for Sezary Syndrome: Likelihood ...

Pembrolizumab is under clinical development by Merck and currently in Phase II f...

Pembrolizumab by Merck for Mycosis Fungoides: Likelihoo...

Pembrolizumab is under clinical development by Merck and currently in Phase II f...

Gedeptin by GeoVax Labs for Nasopharyngeal Cancer: Like...

Gedeptin is under clinical development by GeoVax Labs and currently in Phase II ...

Rimegepant sulfate ODT by Pfizer for Rhinosinusitis: Li...

Rimegepant sulfate ODT is under clinical development by Pfizer and currently in ...

ATX-304 by Amplifier TX for Cardiometabolic Disease: Li...

ATX-304 is under clinical development by Amplifier TX and currently in Phase I f...

Vamorolone by ReveraGen BioPharma for Becker Muscular D...

Vamorolone is under clinical development by ReveraGen BioPharma and currently in...

University of Kentucky bioengineer designs tools to imp...

LEXINGTON, Ky. (Nov. 15, 2023) — One University of Kentucky researcher is workin...